Evidence map›Paper›PMID 35326815›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Fabrication of Ceftriaxone-Loaded Cellulose Acetate and Polyvinyl Alcohol Nanofibers and Their Antibacterial Evaluation.

Youdhestar, Faraz Khan Mahar, Gotam Das, Ayesha Tajammul, Farooq Ahmed, Muzamil Khatri, Sheeraz Khan, Zeeshan Khatri

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

YoudhestarCenter of Excellence in Nanotechnology and Materials, Mehran University of Engineering and Technology, Jamshoro 76062, Pakistan.
Faraz Khan MaharCenter of Excellence in Nanotechnology and Materials, Mehran University of Engineering and Technology, Jamshoro 76062, Pakistan.ORCID 0000-0002-4417-3339
Gotam DasDepartment of Prosthodontics, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0001-9506-6456
Ayesha TajammulDepartment of Water Sanitation and Health Sciences, US-Pakistan Center for Advanced Studies in Water (USPCAS-W), Mehran University of Engineering and Technology, Jamshoro 76060, Pakistan.
Farooq AhmedCenter of Excellence in Nanotechnology and Materials, Mehran University of Engineering and Technology, Jamshoro 76062, Pakistan.
Muzamil KhatriNano Fusion Technology Research Lab, Division of Frontier Fibers, Institute for Fiber Engineering (IFES), Interdisciplinary Cluster of Cutting-Edge Research (ICCER), Shishu University, Tokida 3-15-1, Ueda 386-8567, Japan.ORCID 0000-0003-2187-0681
Sheeraz KhanCenter of Excellence in Nanotechnology and Materials, Mehran University of Engineering and Technology, Jamshoro 76062, Pakistan.
Zeeshan KhatriCenter of Excellence in Nanotechnology and Materials, Mehran University of Engineering and Technology, Jamshoro 76062, Pakistan.

Funding

King Khalid University RGP.1/336/42
6 · The paper itself

Abstract

Nanotechnology provides solutions by combining the fields of textiles and medicine to prevent infectious microbial spread. Our study aimed to evaluate the antimicrobial activity of nanofiber sheets incorporated with a well-known antibiotic, ceftriaxone. It is a third-generation antibiotic that belongs to the cephalosporin group. Different percentages (0, 5%, 10%, 15%, and 20%; based on polymer wt%) of ceftriaxone were incorporated with a polymer such as polyvinyl alcohol (PVA) via electrospinning to fabricate nanofiber sheets. The Kirby-Bauer method was used to evaluate the antimicrobial susceptibility of the nanofiber sheets using

Indexed as

antibioticsceftriaxoneE. colinanofibersS. aureus

Identifiers

PMID35326815
PMCPMC8944567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.